Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,922 | 485 | 91.8% |
| Education | $711.63 | 79 | 8.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,551 | 86 | $0 (2024) |
| PFIZER INC. | $693.73 | 69 | $0 (2024) |
| Astellas Pharma US Inc | $600.29 | 25 | $0 (2024) |
| TherapeuticsMD, Inc. | $543.55 | 29 | $0 (2022) |
| AMAG Pharmaceuticals, Inc. | $509.24 | 76 | $0 (2019) |
| Sumitomo Pharma America, Inc. | $474.62 | 24 | $0 (2024) |
| Amgen Inc. | $365.73 | 19 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $322.79 | 15 | $0 (2023) |
| Myovant Sciences Inc. | $293.53 | 27 | $0 (2022) |
| Evofem Biosciences, Inc. | $272.19 | 17 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $779.25 | 36 | Sumitomo Pharma America, Inc. ($164.01) |
| 2023 | $1,161 | 56 | Sumitomo Pharma America, Inc. ($310.61) |
| 2022 | $1,255 | 79 | ABBVIE INC. ($353.06) |
| 2021 | $1,158 | 72 | AbbVie Inc. ($338.29) |
| 2020 | $481.54 | 29 | AbbVie Inc. ($137.15) |
| 2019 | $1,366 | 98 | AbbVie, Inc. ($281.11) |
| 2018 | $1,320 | 110 | AMAG Pharmaceuticals, Inc. ($228.61) |
| 2017 | $1,111 | 84 | PFIZER INC. ($200.42) |
All Payment Transactions
564 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | iRhythm Technologies, Inc. | Zio monitor (Device), ZIO XT Patch | Food and Beverage | In-kind items and services | $38.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/12/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $35.28 | General |
| Category: Hematology | ||||||
| 11/27/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $24.06 | General |
| Category: Endocrinology | ||||||
| 11/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: Biological | ||||||
| 11/18/2024 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: WOMENS HEALTH | ||||||
| 11/07/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $30.93 | General |
| Category: Hematology | ||||||
| 11/05/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 10/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: Biological | ||||||
| 10/15/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Bone Health | ||||||
| 10/10/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: CONTRACEPTIVE | ||||||
| 09/24/2024 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: WOMENS HEALTH | ||||||
| 09/23/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: HORMONE THERAPY | ||||||
| 09/05/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: UROLOGY | ||||||
| 08/30/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $23.75 | General |
| 08/21/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: Endocrinology | ||||||
| 08/01/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: UROLOGY | ||||||
| 07/30/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $34.49 | General |
| Category: Hematology | ||||||
| 07/25/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: HORMONE THERAPY | ||||||
| 07/24/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Biological | ||||||
| 07/23/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 06/12/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: WOMENS HEALTH | ||||||
| 06/10/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: Biological | ||||||
| 05/15/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $5.19 | General |
| Category: HORMONE THERAPY | ||||||
| 05/09/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: WOMENS HEALTH | ||||||
| 05/01/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $7.65 | General |
| Category: HORMONE THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 953 | 975 | $151,012 | $58,121 |
| 2022 | 12 | 1,013 | 1,029 | $141,706 | $60,684 |
| 2021 | 11 | 1,002 | 1,022 | $128,102 | $60,160 |
| 2020 | 11 | 848 | 868 | $107,084 | $49,762 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77067 | Screening mammography | Office | 2023 | 119 | 119 | $42,007 | $16,138 | 38.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 386 | 386 | $31,010 | $15,865 | 51.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 118 | 128 | $25,600 | $8,589 | 33.6% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 120 | 120 | $25,200 | $6,636 | 26.3% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 91 | 91 | $9,077 | $4,120 | 45.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $4,400 | $1,769 | 40.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 13 | $2,860 | $1,350 | 47.2% |
| 77065 | Diagnostic mammography of 1 breast | Office | 2023 | 11 | 11 | $3,795 | $1,054 | 27.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 17 | 24 | $2,160 | $940.40 | 43.5% |
| 76642 | Limited ultrasound scan of 1 breast | Office | 2023 | 13 | 14 | $2,944 | $927.33 | 31.5% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Office | 2023 | 14 | 16 | $1,680 | $592.69 | 35.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 20 | 21 | $147.00 | $71.61 | 48.7% |
| 87210 | Smear for infectious agents | Office | 2023 | 11 | 12 | $132.00 | $68.40 | 51.8% |
| 77067 | Screening mammography | Office | 2022 | 137 | 137 | $44,753 | $19,192 | 42.9% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 374 | 374 | $29,920 | $15,823 | 52.9% |
| 77063 | Screening 3d breast mammography | Office | 2022 | 137 | 137 | $28,770 | $7,745 | 26.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 106 | 116 | $17,700 | $7,700 | 43.5% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 131 | 131 | $11,135 | $6,082 | 54.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 13 | $2,860 | $1,400 | 49.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 16 | 16 | $3,520 | $1,327 | 37.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 22 | 27 | $2,430 | $1,059 | 43.6% |
| 87210 | Smear for infectious agents | Office | 2022 | 19 | 20 | $220.00 | $115.32 | 52.4% |
| 82120 | Vaginal fluid chemical analysis for bacteria | Office | 2022 | 16 | 16 | $120.00 | $94.88 | 79.1% |
| 81002 | Urinalysis, manual test | Office | 2022 | 26 | 26 | $182.00 | $89.71 | 49.3% |
| 83986 | Body fluid ph level | Office | 2022 | 16 | 16 | $96.00 | $56.70 | 59.1% |
About Dr. Jane Porcelan, MD
Dr. Jane Porcelan, MD is a Specialist healthcare provider based in Bryn Mawr, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922054568.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jane Porcelan, MD has received a total of $8,633 in payments from pharmaceutical and medical device companies, with $779.25 received in 2024. These payments were reported across 564 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($7,922).
As a Medicare-enrolled provider, Porcelan has provided services to 3,816 Medicare beneficiaries, totaling 3,894 services with total Medicare billing of $228,727. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Obstetrics & Gynecology
- Location Bryn Mawr, PA
- Active Since 05/25/2006
- Last Updated 07/18/2024
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1922054568
Products in Payments
- MYFEMBREE (Drug) $735.63
- LO LOESTRIN FE (Drug) $505.01
- INTRAROSA (Drug) $434.86
- PREMARIN (Drug) $399.61
- ORILISSA (Drug) $385.22
- Prolia (Biological) $292.43
- Phexxi (Drug) $272.19
- ANNOVERA (Drug) $270.50
- Kyleena (Drug) $265.53
- DIVIGEL (Drug) $224.27
- Orilissa (Drug) $215.80
- ORIAHNN (Drug) $215.68
- Veozah (Drug) $213.70
- NEXPLANON (Drug) $202.85
- Lupron (Drug) $179.96
- IMVEXXY (Drug) $173.99
- PREMARIN ORALS (Drug) $172.82
- SOLOSEC (Drug) $155.84
- GEMTESA (Drug) $152.62
- Tymlos (Biological) $123.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Bryn Mawr
Stuart Lessin, M.d, M.D
Specialist — Payments: $182,736
Dr. Guy Bernstein, Md, MD
Specialist — Payments: $27,845
Dr. James Duckett, Md, MD
Specialist — Payments: $2,127
Steven Cohen, M.d, M.D
Specialist — Payments: $891.14
Dr. Eric Rosenberg, Md, MD
Specialist — Payments: $260.52
Dr. Michael Lilian, Md, MD
Specialist — Payments: $236.05